• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

1.730 -0.150 (-7.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 229,353
Open 1.860
Bid (Size) 1.730 (500)
Ask (Size) 1.950 (200)
Prev. Close 1.880
Today's Range 1.720 - 2.050
52wk Range 0.6930 - 13.80
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar
June 02, 2026
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology
May 27, 2026
From bioAffinity Technologies, Inc.
Via Business Wire

Performance

YTD
+41.8%
+41.8%
1 Month
-14.4%
-14.4%
3 Month
+68.0%
+68.0%
6 Month
+0.6%
+0.6%
1 Year
-81.0%
-81.0%

More News

Read More
News headline image
bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026
May 12, 2026
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung
May 08, 2026
From bioAffinity Technologies, Inc.
Via Business Wire
Which stocks are experiencing notable movement on Tuesday? ↗
April 28, 2026
Via Chartmill
News headline image
bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment
April 28, 2026
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy
April 14, 2026
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16
April 07, 2026
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026
April 01, 2026
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
What's Going On With bioAffinity Technologies Stock Wednesday? ↗
March 25, 2026
Via Benzinga
News headline image
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice
March 25, 2026
From bioAffinity Technologies, Inc.
Via Business Wire
What's going on in today's session ↗
March 23, 2026
Via Chartmill
These stocks are moving in today's session ↗
March 23, 2026
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
March 20, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
March 20, 2026
Via Chartmill
Discover the top movers in Wednesday's pre-market session. ↗
March 18, 2026
Via Chartmill
These stocks are the most active in today's session ↗
March 17, 2026
Via Chartmill
On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
March 17, 2026
Via Chartmill
Top stock movements in today's session. ↗
March 17, 2026
Via Chartmill
Gapping stocks in Tuesday's session ↗
March 17, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Tuesday. ↗
March 17, 2026
Via Chartmill
News headline image
Why Did BIAF Stock Surge 20% In Pre-Market Today? ↗
March 17, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures
March 17, 2026
From bioAffinity Technologies, Inc.
Via Business Wire
These stocks are moving in today's session ↗
March 16, 2026
Via Chartmill
Gapping stocks in Monday's session ↗
March 16, 2026
Via Chartmill

Frequently Asked Questions

Is bioAffinity Technologies, Inc. - Common Stock publicly traded?
Yes, bioAffinity Technologies, Inc. - Common Stock is publicly traded.
What exchange does bioAffinity Technologies, Inc. - Common Stock trade on?
bioAffinity Technologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for bioAffinity Technologies, Inc. - Common Stock?
The ticker symbol for bioAffinity Technologies, Inc. - Common Stock is BIAF on the Nasdaq Stock Market
What is the current price of bioAffinity Technologies, Inc. - Common Stock?
The current price of bioAffinity Technologies, Inc. - Common Stock is 1.730
When was bioAffinity Technologies, Inc. - Common Stock last traded?
The last trade of bioAffinity Technologies, Inc. - Common Stock was at 06/05/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap